Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...

Anti-obesity medications are often used to help people who have tried and not been able to lose enough weight through exercise and dietary changes. Obesity is a widespread issue affecting over 40% ...

This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...

Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...

Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...